MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor
Authors:
- K Laud-DuvalKLK Laud-Duval
- D BellangerDBD Bellanger
- M-H SternMSM-H Stern
- X Sastre-GarauXSX Sastre-Garau
- O DelattreODO Delattre
- 17 September 2012
- journal article
- Published by Springer Nature in Oncogene
- Vol. 32 (33) , 3915-3921
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes.Keywords
This publication has 52 references indexed in Scilit:
- miR-29 and miR-30 regulate B-Myb expression during cellular senescenceProceedings of the National Academy of Sciences, 2010
- Identification of MicroRNAs Regulating Reprogramming Factor LIN28 in Embryonic Stem Cells and Cancer CellsJournal of Biological Chemistry, 2010
- Recent advances in the molecular pathogenesis of Ewing's sarcomaOncogene, 2010
- EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cellsGenes & Development, 2010
- De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysisNucleic Acids Research, 2010
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targetsThe Journal of Pathology, 2009
- Inducible Expression of Chimeric EWS/ETS Proteins Confers Ewing's Family Tumor-Like Phenotypes to Human Mesenchymal Progenitor CellsMolecular and Cellular Biology, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Mesenchymal Stem Cell Features of Ewing TumorsCancer Cell, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006